BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11200777)

  • 1. Inflammatory breast carcinoma: pathological or clinical entity?
    Amparo RS; Angel CD; Ana LH; Antonio LC; Vicente MS; Carlos FM; Vicente GP
    Breast Cancer Res Treat; 2000 Dec; 64(3):269-73. PubMed ID: 11200777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
    Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
    Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis.
    Zeichner SB; Cavalcante L; Suciu GP; Ruiz AL; Hirzel A; Krill-Jackson E
    Asian Pac J Cancer Prev; 2014; 15(8):3435-41. PubMed ID: 24870735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.
    Laird J; Lok B; Siu C; Cahlon O; Khan AJ; McCormick B; Powell SN; Cody H; Wen HY; Ho A; Braunstein LZ
    Ann Surg Oncol; 2018 Jan; 25(1):154-163. PubMed ID: 29094250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of 70 patients with brain metastases from breast carcinoma.
    Wroński M; Arbit E; McCormick B
    Cancer; 1997 Nov; 80(9):1746-54. PubMed ID: 9351543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.
    Da Ros L; Moretti A; Querzoli P; Pedriali M; Lupini L; Bassi C; Carcoforo P; Negrini M; Frassoldati A
    Clin Breast Cancer; 2018 Oct; 18(5):e1133-e1139. PubMed ID: 29759595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?
    Bonnier P; Charpin C; Lejeune C; Romain S; Tubiana N; Beedassy B; Martin PM; Serment H; Piana L
    Int J Cancer; 1995 Aug; 62(4):382-5. PubMed ID: 7635562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of prognostic features in infiltrating lobular carcinoma of the breast.
    Frost AR; Terahata S; Yeh IT; Siegel RS; Overmoyer B; Silverberg SG
    Mod Pathol; 1995 Oct; 8(8):830-6. PubMed ID: 8552571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction.
    Raghav K; French JT; Ueno NT; Lei X; Krishnamurthy S; Reuben JM; Valero V; Ibrahim NK
    PLoS One; 2016; 11(1):e0145534. PubMed ID: 26752563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological features and prognosis of lobular carcinoma in Egyptian breast cancer patients.
    Azim HA; Malek RA; Azim HA
    Womens Health (Lond); 2014 Sep; 10(5):511-8. PubMed ID: 25335542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval Breast Cancer Versus Screen-Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single-Center Analysis.
    Bellio G; Marion R; Giudici F; Kus S; Tonutti M; Zanconati F; Bortul M
    Clin Breast Cancer; 2017 Nov; 17(7):564-571. PubMed ID: 28456487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
    Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
    J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer at extreme ages--a comparative analysis in Chile.
    Acevedo F; Camus M; Sanchez C
    Asian Pac J Cancer Prev; 2015; 16(4):1455-61. PubMed ID: 25743815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.